X0508 4 2025-10-29 0 0001482981 Vita Coco Company, Inc. COCO 0001886142 Burth Jonathan 111 5TH AVENUE 2ND FLOOR NEW YORK NY 10003 0 1 0 0 Chief Operating Officer 1 Common Stock 2025-10-29 4 M 0 2334 10.178 A 78461 D Common Stock 2025-10-29 4 S 0 2334 47.948 D 76127 D Common Stock 2025-10-29 4 M 0 20000 10.178 A 96127 D Common Stock 2025-10-29 4 S 0 20000 45.711 D 76127 D Non-Qualified Stock Option (right to buy) 10.178 2025-10-29 4 M 0 20000 0.0 D 2029-12-16 Common Stock 20000 8825 D Non-Qualified Stock Option (right to buy) 10.178 2025-10-29 4 M 0 2334 0.0 D 2030-02-10 Common Stock 2334 220616 D Non-Qualified Stock Option (right to buy) 10.178 2031-01-11 Common Stock 34125 34125 D Non-Qualified Stock Option (right to buy) 15.0 2031-10-21 Common Stock 58043 58043 D Non-Qualified Stock Option (right to buy) 15.36 2032-08-15 Common Stock 42980 42980 D Non-Qualified Stock Option (right to buy) 16.91 2033-03-10 Common Stock 14205 14205 D Non-Qualified Stock Option (right to buy) 26.18 2034-03-04 Common Stock 8746 8746 D Non-Qualified Stock Option (right to buy) 33.36 2035-03-04 Common Stock 13218 13218 D The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.71 to $48.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $46.38, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in three equal annual installments beginning on August 15, 2025. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. By: Alison Klein, Attorney-in-Fact For: Jonathan Burth 2025-10-31